Introduction
============

Quality measurement has been a vital component in monitoring the U.S. health care system's quality of care---assessing the effectiveness of quality improvement initiatives and serving as the basis for pay-for-performance programs and public accountability reports \[[@B2]\]. However, current quality measure strategies are limited as they usually (1) focus on processes and treatment goals instead of health outcomes, (2) have a tendency to address a single risk factor or biomarker when patients often have multiple conditions, (3) focus on population thresholds that may not be relevant to individual patient risk \[[@B5]\], and (4) fail to take advantage of opportunities to engage and motivate patients \[[@B3]\].

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in the United States \[[@B4]\], and expenditures continue to be higher for it than for any other diagnostic group, with combined direct and indirect costs estimated at \$320 billion in 2011 alone \[[@B5]\]. A personalized approach to quality measurement that accounts for patient preference could be particularly advantageous in minimizing the overall burden of cardiovascular-related death and disability in the United States. To tackle a problem of this magnitude, we propose to shift the current quality measurement focus from population assessments of individual indicators such as smoking status, hypertension management, and A1C control to one of patient-centric assessment using a model that conveys the likelihood of future adverse events. These patient-driven predicted outcomes can help clinicians recognize the specific characteristics of their patients---optimizing treatment of existing ASCVD---while concurrently improving the overall cardiovascular health of their patients by supporting decision-making in both prevention- and risk reduction discussions. The quality measurement approach proposed here continuously supports population health and incentivizes health care teams to engage patients and individualize care management plans based on goal-oriented, probability-weighted outcomes.

While person-centric risk models are desirable, their application to quality measurement presents a number of challenges. First, quality measure specifications that rely on electronic clinical systems as a primary data source require standard extraction protocols referencing structured data elements within the clinical databases. Current risk prediction tools in the United States are yet to be adopted broadly because they rely on manual searches of nonstandardized and unstructured patient data requiring significant resources \[[@B6]\]. Second, any new quality approach must not add to the existing measurement burden experienced by individual clinicians \[[@B7][@B8]\]. Finally, most predictive modelling tools have been developed for specific patient populations or unique data sets, making effective quality assessment on a larger scale difficult and very expensive \[[@B9]\].

To meet these challenges, a patient-specific approach is needed that highlights those particular factors most relevant to a clinician's treatment of ASCVD on a patient-by-patient basis \[[@B10]\]. Our measure of GCVR scores quantifies how well clinicians manage risk and health outcomes across their entire patient population with respect to individual clinical biomarkers and patient characteristics \[[@B11]\]. Linking contributing variables, derived from multiple sources, into a global, predicted outcome measure that accommodates the nuanced interactions between the ensemble of data points informing a person's risk also provides relevant information about health care quality. The results from these calculations can be specified to assess effectiveness of care at many levels and could stimulate positive change in preventing avoidable events and lowering overall cardiovascular risk. The broader adoption of electronic clinical data systems and quality reporting standards makes it possible to systematically and consistently extract, transform and load (ETL) patient data needed for calculating GCVR, and reduces the burden of manual data extraction and measure calculation. Automating a structured process for clinical data query also introduces the possibility of returning quality information to clinicians in time to actually support decisionmaking. While much recent progress has been made in terms of electronic clinical data standardization and systems interoperability, many clinical practices still do not use standardized data, oftentimes documenting data within free-text fields that are not easily accessible for electronic-based quality measure reporting \[[@B6]\]. Therefore, a necessary first step in changing the quality model for cardiovascular care was systematically evaluating the consistency and completeness of structured electronic data. This paper reports on a pilot effort that investigated whether a standard technical specification could sufficiently define a process that would reliably generate outcome scores from heterogeneous data collected through ECDS.

Methods
=======

NCQA recruited four sites to test the feasibility of generating clinician GCVR scores based on data from each organization's electronic clinical systems. Participating organizations included one nonprofit health plan, one large nonprofit academic medical center, and two integrated health service organizations. Test sites were required to have a fully operational electronic health record system during the measurement period, the ability to warehouse data elements related to cardiovascular risk, and prior experience in reporting quality measure results. In order to obtain patient-level data from external organizations, NCQA first crafted a series of explicit instructions and technical requirements for reporting valid and reliable data. These specifications took the form of a GCVR Data Model (Appendix A) that describes the format of the necessary structured data elements, and a step-by-step process for submission through NCQA's secure portal. A value set directory was also provided, specifically defining each individual data element in the measure using standard terminologies. This field test consisted of retrospective, electronic database research and a small number of key informant interviews assessing clinician views on the topic. A consent form, a semistructured protocol for our key informant interviews, and request for a waiver of Health Insurance Portability and Accountability Act (HIPAA) authorization on behalf of the participating organizations for this study---as allowed by 45 C.F.R. § 164.512(i) of the Privacy Regulations---were reviewed by the Institutional Review Board (IRB). As these data were not created prospectively for research purposes and were therefore determined not to be human subjects research, a waiver of HIPAA authorization for a limited data set was granted by the IRB.

At the start of the process, each component of the technical specification and protocol was first reviewed by independent subject matter experts and then by pertinent experts from each participating organization. Comments and feedback were incorporated as needed prior to going live with data collection. Once data collection was complete, all sites provided detailed feedback on their experience with the technical documentation as well as their personal experiences in programming the queries to extract the requested data elements from their local systems. In order for a new quality measurement approach to be considered feasible, all participating sites must have been able to follow the protocol as instructed and to generate the requested data in sufficient quantity and of sufficient quality for consistent generation of GCVR scores.

Our next step was to select a risk calculator. There are many risk calculator options available---each with its own set of data requirements, a unique algorithm for determining future outcomes, and a variable level of evidence supporting its risk estimations \[[@B12][@B13][@B14][@B15][@B16]\]. For this research, we selected an evidence-based, predictive-risk calculator provided by Archimedes Inc. (<http://www.sphanalytics.com/indigo/>) that utilizes a large number of clinical variables to generate relevant risk predictions for the population under study \[[@B17][@B18]\]. For each individual patient, the Archimedes calculator uses three scalable treatment-outcome scenarios, which are assembled to produce a GCVR score for each provider \[[@B19]\]. Scenario 1 starts by determining a "no care" risk profile by reversing out any current treatments, eliminating the potential benefits of current care in order to estimate risk as if the patient were not under any treatment. Scenario 2 determines a profile for each patient corresponding to actual current performance levels. Scenario 3 determines a "target" by which each patient will have achieved an optimal level of care. Each scenario has a corresponding rate of predicted outcomes. Using each patient's data to determine these three points enables the GCVR score to reflect the proportion of preventable adverse events that are being prevented at current levels of care of the total number of preventable adverse events estimated under optimal care.

Each organization identified an eligible population of patients ages 18 to 85 years whose records included retrospective data collected during the 24-month period between January 1, 2011 and December 31, 2012 and produced a .csv data file populated with patient encounters, health risk assessments, and other electronically available information. One of the integrated delivery systems (IDS 1) and the academic medical center limited their eligibility to patients with a prior diagnosis of hypertension, diabetes, or cardiovascular disease (high-risk population), while the second integrated delivery system (IDS 2) and the health plan included any patient meeting the encounter timing and age criteria. This information was then sent to NCQA via a secure file transfer service for verification and for cataloguing of any of the data elements that were missing or misclassified. Next, the files were securely uploaded to the Archimedes server to generate GCVR scores (Figure [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Finally NCQA matched GCVR scores to clinician National Provider Identifiers (NPIs) and organization IDs in the research database to analyze the calculated GCVR performance results.
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Results
=======

The four organizations successfully returned in excess of 480,000 individual patient records to NCQA for analysis. From this data set, GCVR scores were generated for 2,251 clinicians using 277,780 of those patient records. Records were excluded from the GCVR scoring process due either to data incompleteness for the period under study or to inaccurate data (i.e., not exactly matching the criteria as specified in the technical documentation). We intentionally did not enable any imputation functions available within the Archimedes calculator for this study as we wished to assess the proportion of raw data that could be produced by each of the organizations, following the provided specification. Table [1](#T1){ref-type="table"} presents the aggregated organizational results, illustrating the potential scale of the GCVR score for the total patient population. The *(n)* is the number of patients at each site with sufficient data to generate a GCVR score. Current Averted Events represents the predicted number of events that, under current levels of treatment, will be prevented in that patient sample, and Optimal Averted Events represent the total number of potentially avoidable events in the population if all patients were receiving optimal treatment based on their individual risk profiles. The GCVR score represents the variance between these two estimates for the sample population.

###### 

Organizational GCVR Score by Test Site

  ------------- -------------- --------- ------------------------ ------------------------
                GCVR SCORE\*   *n*       CURRENT AVERTED EVENTS   OPTIMAL AVERTED EVENTS
                                                                  
  IDS 1\*\*     69.7           45,198    1,418                    2,036
  IDS 2         76.5           145,277   1,420                    1,856
  AMC\*\*       59.7           40,155    896                      1,499
  Health Plan   59.1           47,150    346                      585
  ------------- -------------- --------- ------------------------ ------------------------

Notes: \*A higher score is better. \*\* IDS = Integrated Delivery System; AMC = Academic Medical Center.

Table [2](#T2){ref-type="table"} presents the numeric details of the scatter plots for each organization. The *(n)* in Table [2](#T2){ref-type="table"} represents NPIs to which the clinician GCVR scores were attributed within each organization.

###### 

Clinician GCVR Scores by Test Site

  ------------- ------ ------ ------ ------- ------- ------- ------- -------
  SITE          n      AVG    SD     PCT10   PCT25   PCT50   PCT75   PCT90
                                                                     
  IDS 1         1083   70.3   11.2   58.0    66.0    72.2    77.3    81.0
  IDS 2         24     76.0   5.4    74.2    75.2    76.4    77.9    78.3
  AMC           1052   60.1   18.5   32.8    57.1    64.7    72.2    75.6
  Health Plan   92     48.8   21.4   10.6    45.5    55.7    62.4    69.4
  ------------- ------ ------ ------ ------- ------- ------- ------- -------

In testing the feasibility of GCVR, clinician workflow and decision-making about what is transcribed into the patient record was of foremost interest. It became evident that while it is relatively easy to execute electronic queries in many EHRs, altering clinical workflow patterns to accommodate new measure data requirements are difficult if members of the health care team do not immediately see how the change benefits the patient. For this reason, the GCVR team used a process of continuous feedback throughout the testing process as solutions to each of the various technological challenges were considered.

Discussion
==========

Almost 60 percent of the patients in our system had sufficient structured data for us to calculate a GCVR score, demonstrating the feasibility of calculating predicted outcome scores using a large number of patient variables. Despite the increased use of national standards, longitudinal clinical data are still represented in many different formats.

Even relatively common clinical data elements are not always stored in standardized, structured fields; they contain repeating data elements across irregular time frames (e.g., outpatient blood pressure readings) and may include patient assessment information from several settings---posing a difficulty in constructing measures like the GCVR. Because a GCVR-based measurement framework requires more data than does typical performance reporting, our pilot was critical to understanding whether complex technical specifications could be efficiently implemented. Understanding how to communicate necessary data requirements such that they are uniformly interpreted by multiple organizations that can then report valid quality results is crucial in developing a new quality measure. Since our main focus was on feasibility, we needed to deliver a highly specific request in a common format to overcome the lack of standardization and to establish a process by which disparate data sets could be transformed (manually at first, but electronically in the future) to our GCVR data model that would then permit consistent and reliable calculation of outcome scores.

Now that feasibility has been successfully demonstrated, a measure like GCVR can become a cornerstone for a new quality framework that assesses the influence of modifying any one of a patient's factors to see if it affects an individual's likelihood of an adverse event. GCVR offers a unique opportunity to assess progress by relying on advanced technology to identify patients' optimal treatment targets, encouraging clinical preventive strategies that set risk reduction goals, then measuring the attainment of those goal \[[@B20][@B21]\]. As the complexity of electronic clinical data increases and variables indicative of treatment multiply measure developers must consider more efficient ways of assessing clinical care to produce timely and actionable information. An analytic model that accurately predicts cardiovascular outcomes in heterogeneous populations would be useful, despite the additional complexity because the new quality framework prioritizes a patient-centric approach. Our research findings demonstrate that well-defined technical specifications and a protocol requiring structured data can provide such solutions for quality measurement, regardless of site-specific limitations.

Limitations
-----------

The limited scope of this study prevented us from performing a multidimensional quality analysis of the data files, or an evaluation of the semantic and syntactic accuracy of the data extracted \[[@B22]\]. However, our success in producing GCVR scores from heterogeneous clinical data encompassing more than 270,000 patient records demonstrates the feasibility of the process from a data completeness perspective \[[@B23]\]. In the present study certain data types---such as medications and patient history---presented particular challenges that we worked around by requiring that separate files be submitted by participants, which could be individually validated and integrated into the patient-level file. As both measure developers and health care organizations obtain more experience with the level of technical specification required to ensure consistent ETL processes, we expect many of these steps to become unnecessary in future iterations.

Conclusion
==========

To our knowledge, this is the first time that predictive models have been proposed for quality measurement. This pilot successfully demonstrated that a predicted outcome measure is feasible using electronic patient data. However, new specification standards are required before this approach is fully scalable to the level of a national quality reporting program. As experience with reporting measures using ECDS increases, improvements in quality reliability and standardization will follow--facilitating improved cardiovascular risk predictions and advancing new measurement concepts in health care quality assessment. GCVR's transformative strategy offers a valuable opportunity to evaluate quality improvement by assessing patient-specific health outcomes on a national scale.

The author would like to acknowledge the contributions of the following individuals to the development of this paper: Michael Barr, MD, MBA, MACP, Sarah Hudson Scholle, DrPH and Mary Barton, MD.

###### 

NCQA GCVR Common Data Model

  ----------------------------------- --------------------------- -------------------------------------------------------------------- ------ -------------- ---------------------------------------------------------------------------------------------------------------------------- ------------
                                      .CSV VARIABLE INFORMATION                                                                                                                                                                                                                           

  PRIORITY                            DATA ELEMENT                DESCRIPTION                                                          TYPE   FIELD LENGTH   VALUE                                                                                                                        NULL VALUE

                                                                                                                                                                                                                                                                                          

  **PATIENT DEMOGRAPHICS**                                                                                                                                                                                                                                                                

                                                                                                                                                                                                                                                                                          

  Critical                            RAND_ID                     Patient unique identifier                                            Num    10             Any numeric ID unique to an individual patient                                                                               --

  Critical                            Org_ID                      Field Test Organizational ID (assigned by NCQA)                      Char   2              e.g., AA                                                                                                                     --

  Med                                 Provider_ID1                Provider identifier 1                                                Num    10             Any numeric ID unique to an individual provider                                                                              NI

  Med                                 Provider_ID2                Provider identifier 2                                                Num    10             Any numeric ID unique to an individual provider                                                                              NI

  Med                                 Payer_ID                    NCQA Plan ID (if available)                                          Num    5              Numeric ID unique to the primary payer                                                                                       NI

  Med                                 SNAPSHOT_DATE               Date data was extracted (YYYY-MM-DD)                                 Date   10             YYYY-MM-DD                                                                                                                   NI

  High                                DOB_YR                      Patient DOB                                                          Date   7              YYYY-MM                                                                                                                      NI

  Critical                            SEX                         Patient Gender                                                       Char   1              Report the applicable code                                                                                                   --

  low                                 ETHNICITY                   Patient\'s ethnicity                                                 Char   6              Report the applicable code present in the patient\'s record                                                                  NI

  High                                SMOKER                      Tobacco User                                                         Char   12             Report the applicable code present in the patient\'s record.                                                                 NI

  Low                                 RACE                        Patient\'s race                                                      Char   6              Report the applicable code present in the patient\'s record                                                                  NI

  **MEDICAL HISTORY**                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                          

  High                                DM                          Diagnosis Diabetes (Type I or Type II)                               Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_HYP                       Diagnosis Hypertension                                               Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_IHD                       Diagnosis Ischemic Heart Disease                                     Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_ANGI                      Diagnosis Angina                                                     Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_COATH                     Diagnosis Coronary Atherosclerosis                                   Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_CoAO                      Diagnosis Coronary Artery Occlusion                                  Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_CVD                       Diagnosis Cardiovascular Disease                                     Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_OPREA                     Diagnosis Occlusion or Stenosis of Precerebral Arteries              Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_ATH_RA                    Diagnosis Atherosclerosis of Renal Artery                            Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_ATH_EXT                   Diagnosis Atherosclerosis of Native Arteries of the Extremities      Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_OCC_EST                   Diagnosis Chronic Total Occlusion of the Artery of the Extremities   Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_ART_THROM                 Diagnosis Arterial Embolism and Thrombosis                           Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                D_ATH_EMB                   Diagnosis Atheroembolism                                             Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                PREVIOUS_MI                 Previous Acute Myocardial Infarction                                 Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                PREVIOUS_STROKE             Prior Stroke (not including Transient Ischemic Attack)               Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                HF                          Diagnosis Heart Failure                                              Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                AF                          Diagnosis Atrial Fibrillation                                        Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  High                                REVASC                      Prior Revascularization (Coronary Artery Stent or Graft)             Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  Med                                 LVH                         Diagnosis Left-Ventricular Hypertrophy                               Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  N/A                                 GEST_DM                     Gestational Diabetes                                                 Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  N/A                                 ESRD                        End Stage Renal Disease (Stage IV or V CRF or ESRD)                  Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  N/A                                 PREG                        Pregnancy                                                            Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  N/A                                 COGIMP                      Cognitive Impairment                                                 Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  N/A                                 MAJ_DEP                     Major Depression                                                     Char   10             Report code with the period delimiter (if applicable: e.g., 493.10)                                                          NI

  **EXAMINATION**                                                                                                                                                                                                                                                                         

                                                                                                                                                                                                                                                                                          

  High                                WEIGHT                      Weight Measurement (in pounds)                                       Num    3              Report numeric weight (in pounds) e.g., 178                                                                                  NI

  High                                HEIGHT                      Height Measurement (in inches)                                       Num    3              e.g., 072                                                                                                                    NI

  High                                BP1_DATE                    Date of Blood Pressure Measurment                                    Date   10             YYYY-MM-DD                                                                                                                   NI

  High                                BP1_DIA                     Diastolic Blood Pressure Reading (mmHg)                              Num    3              e.g., 090                                                                                                                    NI

  High                                BP1_SYS                     Systolic Blood Pressure Reading (mmHg)                               Num    3              e.g., 140                                                                                                                    NI

  *Labs*                                                                                                                                                                                                                                                                                  

                                                                                                                                                                                                                                                                                          

  High                                A1C1_DATE                   Date of HBA1C lab test                                               Date   10             YYYY-MM-DD                                                                                                                   NI

  High                                A1C1_VAL                    HBA1C lab test result (%)                                            Num    4              e.g., 06.5                                                                                                                   NI

  High                                CHOL1_DATE                  Date of Total Cholesterol Lab Test                                   Date   10             YYYY-MM-DD                                                                                                                   NI

  High                                CHOL1_VAL                   Total Cholesterol Result (mg/dL)                                     Num    3              e.g., 230                                                                                                                    NI

  High                                HDL1_DATE                   Date of HDL Lab Test                                                 Date   10             YYYY-MM-DD                                                                                                                   NI

  High                                HDL1_VAL                    HDL Result (mg/dL)                                                   Num    3              e.g., 055                                                                                                                    NI

  High                                LDL1_DATE                   Date of LDL                                                          Date   10             YYYY-MM-DD                                                                                                                   NI

  High                                LDL1_VAL                    LDL Result (mg/dL)                                                   Num    3              e.g., 101                                                                                                                    NI

  High                                TRIG1_DATE                  Date of Triglyceride                                                 Date   10             YYYY-MM-DD                                                                                                                   NI

  High                                TRIG1_VAL                   Triglyceride Result (mg/dL)                                          Num    3              e.g., 101                                                                                                                    NI

  High                                SERCR1_DATE                 Date of Serum Creatinine                                             Date   10             YYYY-MM-DD                                                                                                                   NI

  High                                SERCR1_VAL                  Serum Creatinine (mg/dL)                                             Num    3              e.g., 1.5                                                                                                                    NI

  High                                FPG1_DATE                   Date of Fasting Plasma Glucose                                       Date   10             YYYY-MM-DD                                                                                                                   NI

  High                                FPG1_VAL                    Fasting Plasma Glucose Result (mg/dL)                                Num    3              e.g., 101                                                                                                                    NI

  **OTC MED STATUS**                                                                                                                                                                                                                                                                      

                                                                                                                                                                                                                                                                                          

  Med                                 ASPIRIN_STATUS              Taking aspirin                                                       Char   10             Report the applicable code present in the patient\'s record                                                                  NI

  Low                                 FISH_OIL_STATUS             Using fish oil or eating equivalent number of fish meals per week    Char   10             Report the applicable code present in the patient\'s record                                                                  NI

  Low                                 NIACIN_STATUS               Taking crystalline niacin                                            Char   10             Report the applicable code present in the patient\'s record                                                                  NI

  **MEDICATION ALLERGY (OPTIONAL)**                                                                                                                                                                                                                                                       

                                                                                                                                                                                                                                                                                          

  High                                ASPIRIN_ALLERGY             Indicates patient is allergic to aspirin                             Char   10             Report the applicable code present in the patient\'s record                                                                  NI

  High                                ACE_ALLERGY                 Indicates patient is allergic to ACE Inhibitors                      Char   10             Report the applicable code present in the patient\'s record                                                                  NI

  High                                ARB_ALLERGY                 Indicates patient is allergic to ARBs                                Char   10             Report the applicable code present in the patient\'s record                                                                  NI

  High                                BETA_ALLERGY                Indicates patient is allergic to Beta Blockers                       Char   10             Report the applicable code present in the patient\'s record                                                                  NI

  High                                CCB_ALLERGY                 Indicates patient is allergic to Calcium Channel Blockers            Char   10             Report the applicable code present in the patient\'s record                                                                  NI

  High                                DIURETIC_ALLERGY            Indicates patient is allergic to diuretics                           Char   10             Report the applicable code present in the patient\'s record                                                                  NI

  High                                STATIN_ALLERGY              Indicates patient is allergic to statins                             Char   10             Report the applicable code present in the patient\'s record                                                                  NI

  **MEDICATION HISTORY**                                                                                                                                                                                                                                                                  

                                                                                                                                                                                                                                                                                          

  High                                DISPENSE_DT                 Date of dispense                                                     Date   10             YYYY-MM-DD                                                                                                                   NI

  Med                                 MED_CAT                     Category of medication                                               Char   15             Antidiabetic, Insulin, ACE, ARB, Beta, CCB, Diuretic, Loop diuretic, Statin, Fibrate, Aspirin, Anticoagulant, Antiplatelet   NI

  High                                GPI/NDC/RxNorm              GPI, NDC, or RxNorm code                                             Num    14             Report the applicable code present in the patient\'s record                                                                  NI

  High                                DAYS_SUPPLY                 Number of days supplied for current dispense                         Num    3              e.g., 090, 230                                                                                                               NI

  High                                QUANTITY                    Amount of medication in dispense.                                    Num    3              e.g., 090, 230                                                                                                               NI

  High                                SOURCE                      Source of prescription information (EHR/Payer)                       Num    2              01 = EHR\                                                                                                                    NI
                                                                                                                                                             02=Payer                                                                                                                     
  ----------------------------------- --------------------------- -------------------------------------------------------------------- ------ -------------- ---------------------------------------------------------------------------------------------------------------------------- ------------
